
21.71 Delayed Data As of Apr 16 | ![]() Today’s Change | 10.52 Today|||52-Week Range 21.99 | +60.93% Year-to-Date |
Previous close | 21.80 |
Today’s open | 21.55 |
Day’s range | 21.55 - 21.97 |
Volume | 17,579 |
Average volume (3 months) | 563,680 |
Market cap | $1.5B |
Earnings growth (last year) | -130.65% |
Earnings growth (this year) | -21.81% |
Earnings growth (next 5 years) | +34.00% |
Revenue growth (last year) | -2.28% |
P/E ratio | NM |
Price/Sales | 2.15 |
Price/Book | 2.82 |
Today’s change | Today’s % change | |
---|---|---|
TRILTrillium Therapeutic... | -0.43 | -4.14% |
VIVOMeridian Bioscience ... | -0.37 | -1.57% |
CLDXCelldex Therapeutics... | +0.02 | +0.08% |
MYGNMyriad Genetics Inc | -1.43 | -4.97% |
Next reporting date | May 4, 2021 |
EPS forecast (this quarter) | -$0.01 |
Annual revenue (last year) | $339.4M |
Annual profit (last year) | -$13.5M |
Net profit margin | -3.97% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters North Billerica, Massachusetts |